ArticlePatient preference and adherence2026
Knowledge, Attitudes, and Practices Regarding Iodine-131 Therapy and Their Association with Depression and Anxiety Among Postoperative Thyroid Cancer Patients Undergoing I-131 Treatment.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to evaluate the knowledge, attitudes, and practices (KAP) regarding iodine-131 (I-131) therapy and their relationship with depression and anxiety in postoperative thyroid cancer patients undergoing I-131 treatment. Patients and Methods: A cross-sectional survey was conducted from January 3, 2025 to October 23, 2025 at the Affiliated Hospital of Zunyi Medical University, Guizhou Provincial People's Hospital, the Affiliated Hospital of Guizhou Medical University, and Zunyi First People's Hospital. Data concerning demographic and clinical characteristics, as well as KAP, were collected using a self-developed questionnaire. Anxiety and depressive symptoms were assessed using the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9), respectively. Results: A total of 386 participants were included. The mean (SD) scores were 9.98 (4.95) for knowledge (possible range: 0-24), 22.71 (4.02) for attitude (possible range: 6-30), and 31.53 (4.42) for practice (possible range: 9-45). Multivariable models revealed that higher knowledge (β=-0.169, 95% CI: -0.279 to -0.058; P=0.003) and practice (β=-0.360, 95% CI: -0.487 to -0.232; P<0.001) were independently associated with lower GAD-7 scores, while practice was also independently correlated with lower PHQ-9 scores (β=-0.435, 95% CI: -0.587 to -0.284; P<0.001). Structural equation modeling (SEM) indicated that knowledge had significant direct associations with attitude (β= 0.502, P = 0.005) and practice (β = 0.518, P = 0.015). Furthermore, knowledge also had a significant indirect association with practice mediated by attitude (β = 0.077, P = 0.043). Conclusion: The level of knowledge regarding the I-131 therapy was found to be low. Higher KAP was associated with lower symptoms of anxiety and depression, and attitude partially mediating the relationship between knowledge and practice. These findings suggest that integrating standardized, targeted education alongside routine GAD-7/PHQ-9 screening and behavior coaching into I-131 care may enhance adherence and improve psychological well-being, although future interventional trials are needed to confirm these clinical benefits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.